Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IDEAYA Biosciences (IDYA) Net Cash Flow (2019 - 2025)

Historic Net Cash Flow for IDEAYA Biosciences (IDYA) over the last 7 years, with Q3 2025 value amounting to $184.3 million.

  • IDEAYA Biosciences' Net Cash Flow fell 1516.89% to $184.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$101.5 million, marking a year-over-year decrease of 14080.97%. This contributed to the annual value of -$72.6 million for FY2024, which is 18153.02% down from last year.
  • As of Q3 2025, IDEAYA Biosciences' Net Cash Flow stood at $184.3 million, which was down 1516.89% from -$15.4 million recorded in Q2 2025.
  • Over the past 5 years, IDEAYA Biosciences' Net Cash Flow peaked at $217.2 million during Q3 2024, and registered a low of -$316.0 million during Q4 2024.
  • For the 5-year period, IDEAYA Biosciences' Net Cash Flow averaged around $12.0 million, with its median value being $5.2 million (2023).
  • In the last 5 years, IDEAYA Biosciences' Net Cash Flow soared by 453906.81% in 2021 and then crashed by 617363.06% in 2024.
  • Quarter analysis of 5 years shows IDEAYA Biosciences' Net Cash Flow stood at -$16.4 million in 2021, then tumbled by 103.41% to -$33.3 million in 2022, then skyrocketed by 115.61% to $5.2 million in 2023, then tumbled by 6173.63% to -$316.0 million in 2024, then soared by 158.32% to $184.3 million in 2025.
  • Its Net Cash Flow stands at $184.3 million for Q3 2025, versus -$15.4 million for Q2 2025 and $45.6 million for Q1 2025.